M. Blouin

发表

Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.

Sébastien Gagné, Eric Langlois, Jean-François Truchon, 2014, Bioorganic & medicinal chemistry letters.

The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor.

Christine Brideau, Yves Ducharme, Marc Ouellet, 2010, ACS medicinal chemistry letters.

Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.

R. Young, J. Mancini, M. Turner, 2003, Journal of medicinal chemistry.

High Energy Ball Milled Nanocrystalline ZnO Varistors

Robert Schulz, Houshang Alamdari, S. Boily, 2000 .

Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding.

Chun Xing Li, J. Yergey, D. Guay, 2002, Bioorganic & medicinal chemistry letters.

2,3-Diarylthiophenes as selective EP1 receptor antagonists.

D. Denis, S. Kargman, G. O'neill, 2005, Bioorganic & medicinal chemistry letters.

Study of ferroelectric microdomains due to oxygen vacancies in KTaO3

P. Grenier, L. Boatner, S. Jandl, 1992 .

Effect of boron on the structural and electrochemical properties of nanocrystalline Ti2RuFeBx electrodes

I. Swainson, L. Roué, D. Guay, 2007 .

A new class of leukotriene biosynthesis inhibitor: the development of MK-0591.

P. Prasit, C. Brideau, C. Chan, 1993, Journal of lipid mediators.

Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor.

R. Young, C. Brideau, D. Guay, 2002, Bioorganic & medicinal chemistry letters.

The discovery of a new structural class of potent orally active leukotriene D4 antagonists

R. Young, P. Prasit, A. Ford-hutchinson, 1992 .

Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses.

R. Young, J. Mancini, R. Friesen, 2006, Journal of veterinary internal medicine.

Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding.

Chun Xing Li, J. Yergey, D. Guay, 2002, Bioorganic & medicinal chemistry letters.

Atomic force microscopy study of the microroughness of SiC thin films

M. Khakani, M. Chaker, D. Guay, 1994 .

Structure and valence properties of ceria films synthesized by laser ablation under reducing atmosphere

D. Guay, A. Péreira, A. Pillonnet, 2014 .

Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors.

C. Brideau, R. Friesen, Y. Girard, 2003, Bioorganic & medicinal chemistry letters.

Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters.

Chun Xing Li, C. Brideau, R. Friesen, 2002, Bioorganic & medicinal chemistry letters.

Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors.

R. Young, D. Éthier, J. Mancini, 2003, Bioorganic & medicinal chemistry letters.

Activation of Ruthenium Oxide, Iridium Oxide, and Mixed RuxIr1 − x Oxide Electrodes during Cathodic Polarization and Hydrogen Evolution

D. Guay, M. Blouin, 1997 .

Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.

J. Falgueyret, D. Riendeau, R. Young, 1998, Bioorganic & medicinal chemistry letters.

A highly stereoselective preparation of a novel class of vinyl epoxides from .alpha.-allenic alcohols

R. Friesen, M. Blouin, 1993 .

A new method for the preparation of aryl vinyl ethers.

R. Frenette, M. Blouin, 2001, The Journal of organic chemistry.

Effect of oxygen and titanium contents on the stability of nanocrystalline Ti–Ru–Fe–O cathode materials for chlorate electrolysis

L. Roué, D. Guay, R. Schulz, 2000 .

Plasma-sprayed nanocrystalline Ti–Ru–Fe–O coatings for the electrocatalysis of hydrogen evolution reaction

L. Roué, D. Guay, R. Schulz, 2002 .

Kinetics of formation of nanocrystalline phases by mechanochemical reaction between Ti and RuO2

D. Guay, R. Schulz, M. Blouin, 1999 .

The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonist.

P. Clark, Steve Rowland, D. Denis, 2010, Journal of medicinal chemistry.

Neutron and in Situ X-ray Investigation of Hydrogen Intake in Titanium-Based Cubic Alloys

I. Swainson, L. Roué, D. Guay, 1999 .

High Energy Ball Milled Nanocrystalline ZnO Varistors

H. Alamdari, R. Schulz, M. Blouin, 2000 .

A new method for the preparation of aryl vinyl ethers.

R. Frenette, M. Blouin, 2001, The Journal of organic chemistry.

Regiospecific and highly stereoselective formation of benzisochroman-6,9-quinones. Synthesis of (.+-.)-ventilagone and (.+-.)-ventiloquinone H

M. Blouin, P. Brassard, M. Béland, 1990 .

Comparative Study of the Electrochemical Behavior of Polycrystalline and Nanocrystalline Ru Powder in NaOH Solution

L. Roué, D. Guay, R. Schulz, 1998 .

Nanophase semi-conductive ceramics: dielectric surface performance when exposed to charges

R. Larocque, M. Blouin, Michel F. Fréchette, 2004, The 17th Annual Meeting of the IEEE Lasers and Electro-Optics Society, 2004. LEOS 2004..